Group One Trading, L.P. Abb Vie Inc. Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $2.7 Million - $3.15 Million	-17,429 Reduced 52.75%	15,610 $2.68 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $5.28 Million - $6.02 Million	33,039 New	33,039 $6.02 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $4.85 Million - $5.69 Million	-56,443 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $5.82 Million - $7.79 Million	-79,339 Reduced 58.43%	56,443 $5.54 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $8.76 Million - $13.3 Million	135,782 New	135,782 $10.3 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $7.5 Million - $9.39 Million	-104,044 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $6.81 Million - $8.19 Million	-108,201 Reduced 50.98%	104,044 $7.88 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $11.8 Million - $15.1 Million	179,471 Added 547.6%	212,245 $15.4 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $2.28 Million - $2.68 Million	29,560 Added 919.73%	32,774 $2.64 Million
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $1.8 Million - $2.22 Million	-23,149 Reduced 87.81%	3,214 $296,000
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $4,623 - $5,139	52 Added 0.2%	26,363 $2.49 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $1.26 Million - $1.49 Million	-14,072 Reduced 34.85%	26,311 $2.44 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $3.72 Million - $4.98 Million	40,383 New	40,383 $3.82 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.